Healthcare and Consumer Staples ETFs Drop 5–6% as Classic Defense Play Fails
- Health Care Select Sector ETF has fallen roughly 5% since the latest geopolitical escalation.
- Consumer Staples Select Sector ETF is down about 6%, underperforming the S&P 500’s 3% decline.
- Technology Select Sector ETF has lost less than 1%, while energy names surge with oil.
- Managers blame pre-war overcrowding, rich valuations, and sector-specific structural problems.
- Shift underscores how inflation and competitive threats have eroded traditional safe-haven appeal.
The flight-to-quality playbook that worked in 2022 is misfiring, forcing allocators to rewrite risk models.
NEW YORK—When tanks rolled into Ukraine in February 2022, global fund managers dumped cyclicals and parked cash in healthcare, household goods, and utilities. The playbook was simple: own companies that sell toothpaste, surgeries, and electricity—products consumers buy even when missiles fly. Fast-forward to today and that script has flipped. Despite fresh geopolitical jitters, the Health Care Select Sector ETF has dropped roughly 5% and the Consumer Staples Select Sector ETF has shed about 6%, while the tech-heavy Nasdaq-100 hovers near break-even and crude has vaulted above $90 a barrel.
The breakdown signals something deeper than short-term volatility. Investors say the pillars that once gave defensives their defensive characteristics—predictable cash flows, pricing power, and starting valuations—have cracked under the weight of lingering inflation, private-label competition, and post-pandemic consumer shifts. Meanwhile, large-cap software and chip designers—long viewed as high-beta casualties of war—now trade like relative havens thanks to cash-rich balance sheets and limited direct exposure to commodity shocks.
“The market’s gaze shifted from white-collar labor displacement and SaaS-mageddon to war,” Nick Puncer, managing director at Bahl & Gaynor, told the Journal. In other words, the cleanest house on a messy street suddenly looks like the safest. The result is an unusual bifurcation: energy and tech are advancing in tandem, while the traditional safety nets lag a broad index that itself is down only mid-single digits.
Rotation Within a Rotation Left Defensives Crowded
By the time headlines turned to troop movements, the so-called safety trade was already overcrowded. Data from Bank of America show that in the four weeks preceding the conflict, equity mutual and ETF flows poured $7.3 billion into healthcare and consumer staples—the fastest four-week pace since the 2021 reopening boom. Portfolio managers had been seeking shelter from a different menace: the AI sell-off that shaved more than 10% off the Nasdaq in a month. Valuations in those defensive sectors, which entered 2023 at a modest discount to the S&P 500, ballooned to a 12% premium as a result.
That front-loaded positioning left little room for incremental buyers once geopolitical risk spiked. “When everyone is already hiding in the same corner, that corner ceases to be safe,” says Lori Calvasina, head of U.S. equity strategy at RBC Capital Markets. Her team’s factor work shows that staples and healthcare now screen in the 80th percentile for ownership relative to history, a contrarian red flag that historically precedes 3–5% underperformance over the next quarter.
Valuation Cushion Vanishes
Even before the latest shock, the sector’s earnings multiple had expanded to 19.5× forward earnings, a 24% premium to its ten-year median, according to FactSet. With real yields on 10-year TIPS hovering near 2%, that spread offers slim margin for disappointment. When Campbell Soup warned that private-label soup and Goldfish crackers were losing shelf space, the stock crumbled 13% in two sessions, dragging the entire staples complex lower. The episode underscored how stretched valuations amplify minor earnings wobbles into sector-wide repricing events.
Adding to the pressure, hedge-fund net exposure to defensives hit its highest level since COVID-19 lockdowns, CFTC Commitment of Traders data reveal. That crowded long base accelerates selling when macro headlines turn because risk-parity funds and commodity-trading advisers unwind symmetrical bets. The result: an ETF such as XLP sees outsized volume spikes—Tuesday’s turnover was 2.8× its 20-day average—even though the underlying holdings are low-beta names like Procter & Gamble and Coca-Cola.
The upshot is a paradox: the very act of seeking safety has rendered these stocks unsafe in the short run. Until positioning normalizes, expect violent two-way flows rather than the steady grind higher that characterized prior geopolitical scares.
The next chapter explores why the structural headwinds—from GLP-1 weight-loss drugs to retailer consolidation—may keep those valuations from rebounding even after crowded positioning clears.
GLP-1 Drug Boom Is Reshaping Food Volumes
Campbell’s 7% post-earnings plunge on Wednesday—and another 6% slide Thursday—highlights a threat that has nothing to do with missile trajectories: GLP-1 receptor agonists. Medications such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound suppress appetite so effectively that early data from Evercore ISI suggest users cut daily caloric intake by 20–30%. With 13 million Americans already prescribed the drugs and CVS Health projecting 30 million by 2028, packaged-food CEOs are quietly modeling mid-single-digit volume headwinds.
General Mills, Conagra, and Kraft Heinz each derive 35–40% of revenue from snacks and baking mixes—the very categories analysts expect to decline first as waistlines shrink. “The market is slowly pricing in a post-obesity economy,” says Robert Moskow, packaged-food analyst at Credit Suisse. His channel checks show Walmart and Kroger allocating more aisle space to store brands, pressuring pricing power at precisely the moment commodity costs for sugar and cocoa are surging. The net result: volume down 3% year-to-date for the sector, pricing up only 2%, and EBITDA margins contracting 120 basis points.
Private-Label Share Accelerates
Private-label dollar share in center-of-store categories has jumped to 24.1%, the highest since NielsenIQ began tracking in 2010. Retailers like Target and Dollar General have expanded their own trail-mix, soup, and cracker lines at 20–30% discounts to national brands. Because staples companies already operate at razor-thin gross margins—Campbell’s sits at 29% versus 42% for the median S&P 500 firm—there is little room to match promotions without sacrificing profit. That dynamic explains why organic revenue guidance for the group has fallen from 4% in January to 1% today, even as input-cost inflation moderates.
The macro overlay compounds the issue. A K-shaped economy funnels spending toward either luxury or deep value, squeezing mid-priced legacy brands. Morgan Stanley’s consumer survey finds households earning $50–100 k plan to cut branded food purchases by 6% next quarter, double the rate of upper-income cohorts. The bifurcation favors retailers’ private labels and ultra-premium organic entrants, leaving mainstream staples in a profit vice.
Until companies either innovate toward protein-enriched SKUs that align with GLP-1 lifestyles or consolidate to gain shelf-scale, investors may continue to treat the group as a value trap rather than a haven. That structural narrative, rather than daily war headlines, is what ultimately caps multiple expansion.
Tech Offers a ‘Clean’ Exposure Profile
While staples struggle with calories and coupons, technology is benefiting from a perception shift. Unlike industrials or materials, large-cap software firms do not consume oil or ship widgets through the Red Sea. Their cost structure is dominated by skilled labor and stock-based compensation—expenses that inflate more gradually than diesel or copper. That relative insulation makes names such as Microsoft, Adobe, and Salesforce attractive when energy volatility grabs the spotlight.
Equally important, many mega-tech names entered the geopolitical scare 25–30% below their 2021 peaks, leaving room for valuation expansion. “We’re paying 24× next-twelve-month free cash flow for a business growing 15% with net cash—versus 19× for a no-growth cereal maker,” notes Travis Axel, portfolio manager at Gabelli Funds. That spread, he argues, offers a rare GARP (growth at reasonable price) profile inside a market starved for defensive growth.
AI Capex Cycle Still Intact
Despite fears of a spending cliff, Microsoft and Alphabet both guided cloud and AI-related capex above consensus this quarter. Semiconductor equipment makers ASML and Applied Materials cited accelerating orders from fabs rushing to secure limited EUV capacity before potential export restrictions tighten. The durability of that capex cycle underpins revenue visibility for software and hardware alike, giving investors a fundamental reason to bid the stocks beyond mere flight-to-quality sentiment.
Options positioning also tilts favorably. Goldman Sachs’ derivatives desk notes that net call open interest on the Technology Select Sector ETF sits at its lowest level since last October, suggesting hedging overshoot. As macro fears ebb, dealers’ delta hedging could create a mechanical tailwind—an accelerant absent from already-crowded staples trades.
The net result is a sector that behaves like a bond proxy during rate scares yet still offers the upside of secular growth when macro clouds part. Until real yields spike above 2.5% or regulation clips AI margins, tech’s new-found defensive luster is likely to persist.
Is Energy the Only True Inflation Hedge Left?
Oil’s 15% jump since the latest geopolitical escalation has revived the oldest inflation hedge of all: energy producers. But today’s sector is structurally different from the shale-boom days. Capital-discipline mandates, labor shortages, and service-cost inflation have flattened the cost curve, meaning every $10-per-barrel increment in Brent now adds roughly $12 billion in free cash flow to the S&P 500 energy cohort—cash largely earmarked for buybacks and variable dividends rather than new rigs.
That capital-return ethos creates a direct conduit from headline-driven spot prices to shareholder distributions. Occidental Petroleum, for instance, guided that at $85 WTI it can repurchase 5% of shares outstanding annually while keeping net debt flat. At $95, that buyback yield jumps to 8%, according to Rystad Energy models. Investors starved for inflation-linked cash flow thus treat energy equities as floating-rate notes keyed to crude futures.
Producer Discipline Caps Supply Response
U.S. shale output growth has slowed to 300 k bbl/day per year, down from 1.6 M bbl/day in 2018, as drillers face investor pressure to prioritize returns over volume. Meanwhile, OPEC+ spare capacity remains thin at 3.5 M bbl/day, the lowest since 2014. The tight backdrop amplifies price sensitivity to any disruption, reinforcing energy’s role as portfolio ballast when CPI prints hot.
ETF flows corroborate the thesis. Energy Select Sector SPDR has absorbed $2.7 billion in new money over the past month, the strongest inflow on record, eclipsing even the 2022 Ukraine invasion spike. Unlike tech, where valuations re-rate, energy’s appeal is pure cash-flow acceleration—making it the last sector where investors can still buy an explicit inflation pass-through.
Yet concentration risk looms. Chevron and Exxon alone account for 43% of the sector weight, meaning an idiosyncratic event—say, a California emissions ruling—could blunt the hedge. Diversification across oil-services names such as Schlumberger or midstream pipelines can mitigate single-stock exposure while preserving commodity beta.
What the Broken Playbook Means for Asset Allocation
The breakdown of traditional safe-haven leadership is forcing allocators to rewrite the 60/40 playbook. BlackRock’s latest Global Chief Investment Officer survey shows that for the first time since 2007, institutions are underweight both healthcare and consumer staples while simultaneously adding to tech and energy. The shift marks a philosophical pivot: instead of sector labels, managers now rank holdings by balance-sheet optionality and pricing power versus the specific inflation regime.
Parametric Portfolio Associates recommends a barbell: 35% of equity exposure in cash-flow-rich energy names, 30% in secular-growth tech, and the remainder in short-duration TIPS. The blend captures real-asset upside while limiting drawdowns should yields fall. J.P. Morgan Private Bank goes further, substituting a 5% allocation to gold miners and railroads for staples, arguing that operating leverage to commodity inflation plus oligopolistic pricing offers purer hedges than food makers caught in a calorie-contraction cycle.
Risk Parity Funds Retool Models
Risk-parity funds that rely on low cross-asset correlations are also recalibrating. AQR Capital notes that the rolling 60-day correlation between healthcare and long-dated Treasuries has flipped from negative 0.2 to positive 0.3 this year, undermining diversification. To restore balance, allocators are raising exposure to Japanese yen and copper miners, assets whose return streams remain negatively correlated to both equities and real rates.
For retail investors, the simplest takeaway is to stop equating low beta with safety. A low-vol healthcare stock trading at 20× earnings with declining volumes may be riskier than a 5%-yielding oil major with variable dividends keyed to CPI. Until inflation falls sustainably toward 2%, expect the old defensive leaders to lag and for the market to reward companies that can either pass through higher costs or grow fast enough to outrun them.
The next shock may not look like the last one, but portfolios anchored to yesterday’s safe havens could prove the riskiest bet of all.
Frequently Asked Questions
Q: What sectors are considered safe-haven stocks?
Utilities, consumer staples, and healthcare are the classic defensive sectors investors buy when geopolitical or macro shocks hit. These groups sell non-discretionary goods and services, so earnings historically hold up better in recessions.
Q: Why are healthcare ETFs down 5% despite new geopolitical risk?
Managers say the group was already overcrowded after a pre-war rotation out of tech, leaving valuations stretched. Add structural pressure—such as drug-pricing scrutiny and hospital staffing inflation—and the sector offers neither valuation cushion nor earnings momentum.
Q: Is technology now viewed as a defensive sector?
Not traditionally, but mega-cap software and AI leaders have balance-sheet cash, wide margins, and limited direct energy or supply-chain exposure to the conflict. That ‘clean’ profile, plus cheaper entry points after last year’s selloff, is attracting nervous asset allocators.
